The United States should resume Johnson & Johnson Covid-19 vaccinations, an expert panel recommended to health authorities on Friday, after a pause prompted by blood clot concerns.
“The Janssen Covid-19 vaccine is recommended for persons 18 years of age and older in the US population under the FDA, emergency use authorization,” the group convened by the Centers for Disease Control and Prevention said.
More to follow . . .